celecoxib has been researched along with deoxynivalenol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chaturvedi, S; Dewangan, J; Divakar, A; Kumar, S; Mandal, P; Mishra, S; Rath, SK; Srivastava, S; Tripathi, A; Wahajuddin, M | 1 |
Asthana, S; Chaturvedi, S; Dewangan, J; Divakar, A; Kumar, S; Mishra, S; Rath, SK; Sharma, D; Srivastava, S; Wahajuddin, M | 1 |
2 other study(ies) available for celecoxib and deoxynivalenol
Article | Year |
---|---|
Celecoxib reduces Deoxynivalenol induced proliferation, inflammation and protein kinase C translocation via modulating downstream targets in mouse skin.
Topics: Animals; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Inflammation; Mice; Protein Kinase C; Signal Transduction; Skin; Skin Diseases; Trichothecenes | 2020 |
N-acetyl-cysteine in combination with celecoxib inhibits Deoxynivalenol induced skin tumor initiation via induction of autophagic pathways in swiss mice.
Topics: Acetylcysteine; Animals; Autophagy; Celecoxib; Mice; Skin Neoplasms; Trichothecenes | 2020 |